In particular, soluble ACE concentration was lower before pacemaker implantation than in the healthy individuals and in patients with hypertension with preserved ejection fraction and it increased in parallel with the improvement of cardiac function (Figure 6B). This evidence concerns the gene ACE and hypertensive disorder.